Drugs / Bioceramides
last change Mar 2026 re-read 2 minutes ago

Bioceramides

Developed for
hyperpigmentation of the skin
Investigated by
COTY BRASIL COMERCIO S.A. · Hospital Israelita Albert Einstein

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT07618572 Mar → Oct 2026 expected hyperpigmentation of the skin Hospital Israelita Albert Einstein Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Bioceramides “cleanser (0.2% Bioceramides), moisturizer (2% Niacinamide + 1% Bioceramides), serum (5% Niacinamide + 3% Bioceramides), and SPF 30 sunscreen” NCT07618572